Quality Systems

Oct 15, 2016
BioPharm International
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Oct 02, 2016
BioPharm International
Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.
Oct 01, 2016
BioPharm International
A new virus-retentive membrane may be used to filter chemical-defined cell culture media for risk mitigation.
Oct 01, 2016
BioPharm International
High-purity low-endotoxin sugars improve robustness and stability of protein formulation and improve drug product quality.
Oct 01, 2016
BioPharm International
Ensuring that drugs retain their safety and efficacy requires careful selection of temperature-control technologies.
Sep 30, 2016
By BioPharm International Editors
Could grading finished-drug manufacturers on their quality and efficiency lead to greater transparency, improve quality and reduce drug shortages?
Sep 23, 2016
By BioPharm International Editors
Hebei Yuxing Bio-Engineering Co. Ltd. was cited for data integrity violations.
Sep 16, 2016
By BioPharm International Editors
EMA has recommended halting supply of non-critical drugs from Pharmaceutics International Inc. because of GMP failures.
Sep 14, 2016
By BioPharm International Editors
FDA sent a warning letter to an Illinois compounding pharmacy for violations of the Federal Food, Drug, and Cosmetic Act.
Sep 12, 2016
By BioPharm International Editors
The company voluntarily recalled the product due to detached needles on the syringe in the kit.
native1_300x100
lorem ipsum